help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0237
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
22/1/176    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K.
Right arrow Articles by Kim, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K.
Right arrow Articles by Kim, N.

Submitted on May 8, 2007
Accepted on September 11, 2007

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and DC-STAMP

Kabsun Kim, Seoung-Hoon Lee, Jung Ha Kim, Yongwon Choi, and Nacksung Kim*

National Research Laboratory for Regulation of Bone Metabolism and Disease, Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju 501–746, Korea; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19014, USA

* To whom correspondence should be addressed. E-mail: nacksung{at}jnu.ac.kr.

NFATc1 has been characterized as a master regulator of RANKL-induced osteoclast differentiation. Herein, we demonstrate a novel role for NFATc1 as a positive regulator of RANKL-mediated osteoclast fusion as well as other fusion-inducing factors such as TNF-{alpha}. Exogenous overexpression of a constitutively active form of NFATc1 in bone marrow-derived monocyte/macrophage cells (BMMs) induces formation of multinucleated osteoclasts as well as the expression of fusion-mediating molecules such as the d2 isoform of vacuolar ATPase Vo domain (Atp6v0d2) and the dendritic cell-specific transmembrane protein (DC-STAMP). Moreover, inactivation of NFATc1 by cyclosporin A treatment attenuates expression of Atp6v0d2 and DC-STAMP and subsequent fusion process of osteoclasts. We show that NFATc1 binds to the promoter regions of Atp6v0d2 and DC-STAMP in osteoclasts and directly induces their expression. Furthermore, overexpression of Atp6v0d2 and DC-STAMP rescues cell-cell fusion of pre-osteoclasts in spite of reduced NFATc1 activity. Our data indicate for the first time that the NFATc1/Atp6v0d2 and DC-STAMP signaling axis plays a key role in the osteoclast multinucleation process, which is essential for efficient bone resorption.


Key words: osteoclast • fusion • NFATc1 • gene expression




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. H. Lee, T. Kim, D. Jeong, N. Kim, and Y. Choi
The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation
J. Biol. Chem., April 25, 2008; 283(17): 11526 - 11534.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society